In addition, AMPKα1 regulates the immunosuppressive activity and differentiation of tumor-MDSC by regulating the differentiation of monocytic-MDSC (mMDSC) to macrophages, suggesting AMPK inhibition as a potential therapeutic strategy to restore protective myelopoiesis in cancer40. This evidence concerns the gene PRKAA2 and neoplasm.